• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用冷冻保存的尿激酶恢复血栓形成导管的通畅性。

Restoring patency of thrombosed catheters with cryopreserved urokinase.

作者信息

Gale G B, O'Connor D M, Chu J Y, Stanley D

出版信息

JPEN J Parenter Enteral Nutr. 1984 May-Jun;8(3):298-9. doi: 10.1177/0148607184008003298.

DOI:10.1177/0148607184008003298
PMID:6539832
Abstract

In order to eliminate wasting vials of urokinase, 5000 U/ml aliquots were reconstituted and frozen. The urokinase remained effective for clearing thrombosed catheters for as long as 9 months. When catheters become occluded, patency can be restored by previously frozen urokinase.

摘要

为了避免浪费尿激酶瓶剂,将其以5000 U/ml的分装量进行复溶并冷冻。尿激酶在长达9个月的时间里仍能有效清除血栓形成的导管。当导管堵塞时,先前冷冻的尿激酶可恢复其通畅性。

相似文献

1
Restoring patency of thrombosed catheters with cryopreserved urokinase.用冷冻保存的尿激酶恢复血栓形成导管的通畅性。
JPEN J Parenter Enteral Nutr. 1984 May-Jun;8(3):298-9. doi: 10.1177/0148607184008003298.
2
Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase.血栓形成的中心静脉导管:在大剂量尿激酶治疗失败后,通过6小时尿激酶输注恢复功能。
JPEN J Parenter Enteral Nutr. 1992 Mar-Apr;16(2):129-32. doi: 10.1177/0148607192016002129.
3
High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Clin Nephrol. 2010 Oct;74(4):297-302. doi: 10.5414/cnp74297.
4
Alteplase versus urokinase for occluded hemodialysis catheters.阿替普酶与尿激酶用于治疗闭塞性血液透析导管
Ann Pharmacother. 2003 Jan;37(1):27-33. doi: 10.1345/aph.1C105.
5
Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.持续输注低剂量尿激酶治疗婴幼儿中心静脉导管血栓形成
Pediatrics. 1989 Jun;83(6):963-6.
6
Lytic therapy in central venous catheters for hemodialysis.用于血液透析的中心静脉导管的溶栓治疗。
Nephrol Nurs J. 2002 Aug;29(4):355-60; quiz 361-2.
7
Urokinase infusion for thrombosed catheters.
JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6):596-7. doi: 10.1177/0148607192016006596.
8
Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C.重组组织型纤溶酶原激活剂在-30℃下的稳定性与无菌性
Lancet. 2000 Jun 24;355(9222):2221-2. doi: 10.1016/S0140-6736(00)02411-9.
9
Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int. 2009 Jun;18(101):118.
10
Dilution of urokinase used to treat thrombus formation in central venous catheters.用于治疗中心静脉导管血栓形成的尿激酶稀释液。
ANNA J. 1997 Aug;24(4):457-8.

引用本文的文献

1
Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.肠外营养的通路技术及其问题——《肠外营养指南》第9章
Ger Med Sci. 2009 Nov 18;7:Doc19. doi: 10.3205/000078.